John R. Stuelpnagel, Director at 10x Genomics, Inc. (TXG), sold 5,000 shares at $191.97 ($958K) on 2021-07-01, disclosed to the SEC on 2021-07-06.
Open-market sale of $958k TXG by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $189.94 | 1,600 | $304K | 31.7% |
| 2 | $190.87 | 1,300 | $248K | 25.9% |
| 3 | $191.97 | 700 | $134K | 14.0% |
| 4 | $193.51 | 700 | $135K | 14.1% |
| 5 | $194.29 | 500 | $97K | 10.1% |
| 6 | $196.00 | 200 |
| $39K |
| 4.1% |
| Total | $191.64 avg | 5,000 | $958K | 100% |
| Filing → |
| TXG | SELL | 2023-06-07 | $549K | — | Filing → |
| TXG | SELL | 2022-01-04 | $1.5M | — | Filing → |
| TXG | SELL | 2021-12-03 | $756K | — | Filing → |